## Note
nid: 1496864920755
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::*Basics, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::21_Cetuximab_Panitumumab, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::23_Rituximab, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::23_Rituximab::*Basics, #AK_Step1_v11::#OME_banner::Basic_Science::07_Immunology, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::02_Rituximab, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::03_Cetuximab,_Panitumumab, #AK_Step1_v11::#Pixorize::03_Pharm::11_Oncology::Cetuximab,_Panitumumab, #AK_Step1_v11::#Pixorize::03_Pharm::11_Oncology::Rituximab, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Rituximab,_cetuximab,_bevacizumab,_alemtuzumab,_trastuzumab::zanki_extra, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::3-HighYield-temporary
markdown: false

### Text
<div>
  <div>
    <u>Chimeric biologics</u> can be recognized as their names will
    include the infix <i>-{{c1::<b>xi</b>}}-</i>
  </div>
</div>

### Extra
<div>
  <i>(ex Rituximab, Cetuximab)</i>
</div>
<div>
  <i>Chimeric biologics are part animal-part human in its origin -
  therefore the immune system will think this biologic is a bad guy
  and generate antibodies against it</i>
  <div>
    <i><img src="paste-48125108551681.jpg"></i>
  </div>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-34286723923971.jpg"><img src=
"paste-34359738368003.jpg"><img src=
"paste-34398393073667.jpg"><img src="paste-34540126994435.jpg">

### Sketchy
<img src="paste-390537081257985.jpg" class="resizer"><img src=
"paste-87d74ac95a67d78e1a0443bd770c17f44240fcf8.png" class=
"resizer"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-antineoplastics/videos/medical-pharmacology-antineoplastics-kinase-inhibitors-and-monoclonal-antibodies-rituximab-cetuximab-bevacizumab-alemtuzumab-trastuzumab?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch Rituximab, cetuximab, bevacizumab, alemtuzumab,
trastuzumab</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/immunology?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_6.png"></a>
</div>

### Additional Resources


### One by one

